tipifarnib has been researched along with geraniol in 2 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (geraniol) | Trials (geraniol) | Recent Studies (post-2010) (geraniol) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 709 | 9 | 437 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crovella, S; De Leo, L; Decorti, G; Marcuzzi, A; Pontillo, A; Tommasini, A | 1 |
| Crovella, S; Kleiner, G; Marcuzzi, A; Monasta, L; Piscianz, E; Tricarico, PM; Zanin, V | 1 |
2 other study(ies) available for tipifarnib and geraniol
| Article | Year |
|---|---|
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
Topics: Acyclic Monoterpenes; Alendronate; Animals; Anti-Inflammatory Agents; Cell Line; Child; Child, Preschool; Cholesterol; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Inflammation Mediators; Lovastatin; Male; Mevalonate Kinase Deficiency; Mice; Monocytes; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Polyenes; Polyisoprenyl Phosphates; Polyunsaturated Alkamides; Pyridines; Quinolones; Terpenes | 2011 |
Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study.
Topics: Acyclic Monoterpenes; Anti-Inflammatory Agents; Apoptosis; Biosynthetic Pathways; Carrier Proteins; Child; Cytokines; Female; Humans; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Male; Mevalonate Kinase Deficiency; Mevalonic Acid; NLR Family, Pyrin Domain-Containing 3 Protein; Quinolones; Temperature; Terpenes | 2013 |